By Charles Toutant | April 14, 2023
"Defendant indeed spoke words, but did not provide answers, thereby preventing effective examination," Special Master Dennis Cavanaugh said of the lawyer's performance at the first deposition.
By Chris O'Malley | April 12, 2023
Bob Bailey is retaking the legal reins of the eye care giant after a decade away. He'll work under recently hired CEO Brent Saunders, whom he formerly worked for at three companies.
The Legal Intelligencer | Event
By Amanda O'Brien | March 29, 2023
Attorneys shouldn't fear having their actions thrown back at a corporation if it becomes a defendant. "Your job as a lawyer is to distinguish things," Brian Savage argued at a forum hosted by Dechert.
By Charles Toutant | March 15, 2023
"Whenever a truthful answer would reflect poorly on him, Mr. Rosebush would veer off course and reiterate—often with identical words, emphases, cadence, and gestures—his scripted, and completely non-responsive, speech about the nature of the PBM audits," the Roche motion says.
By Michael A. Mora | March 8, 2023
"No one should be subjected to this unreasonable risk of harm just by getting products they need on a daily basis," said Ryan Yaffa, who is among the attorneys who represent the plaintiff.
By Chris O'Malley | March 2, 2023
"If a company has acquired or maintained monopoly power through anticompetitive means, they're liable under the antitrust laws whether or not they're exploiting their monopoly power by charging monopoly prices," said Daniel Crane, a professor at the University of Michigan Law School.
By ALM Staff | March 1, 2023
This suit was surfaced by Law.com Radar. Read the document here.
By Amanda Bronstad | February 23, 2023
"This continues to grow into something that's larger than we first anticipated," said Ashlie Case Sletvold, of Peiffer Wolf Carr Kane Conway & Wise in Cleveland, who has filed two cases against Horizon Therapeutics, which makes Tepezza.
National Law Journal | Analysis|News
By Avalon Zoppo | February 10, 2023
The statutory question at the center of the appeals could create a circuit split that brings the issue to the U.S. Supreme Court, said one court watcher.
By Charles Toutant | February 9, 2023
"As a result of this opinion, millions of American consumers and insurers will now have the opportunity to band together and seek justice against the manufacturers, retail pharmacies, and wholesalers who manufactured, distributed, and dispensed adulterated valsartan-containing drugs in the United States," said attorney John Davis of Slack Davis Sanger in Austin, Texas.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...